PubMed

Risk stratification with the risk chart from the European Society of Hypertension compared with SCORE in the general population.

Sehestedt T, Jeppesen J, Hansen TW, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Olsen MH.

J Hypertens. 2009 Dec;27(12):2351-7.PMID: 19915482 [PubMed - in process]Related articles

Impact of hypertension on left ventricular structure in patients with asymptomatic aortic valve stenosis (a SEAS substudy).

Rieck AE, Cramariuc D, Staal EM, Rossebø AB, Wachtell K, Gerdts E.

J Hypertens. 2009 Oct 19. [Epub ahead of print]PMID: 19844185 [PubMed - as supplied by publisher]Related articles

Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.

Okin PM, Wachtell K, Kjeldsen SE, Julius S, Lindholm LH, Dahlöf B, Hille DA, Nieminen MS, Edelman JM, Devereux RB.

Circ Arrhythm Electrophysiol. 2008 Dec;1(5):337-43. Epub 2008 Dec 2.PMID: 19808428 [PubMed - indexed for MEDLINE]Related articles

Mitral E wave deceleration time to peak E velocity ratio and cardiovascular outcome in hypertensive patients during antihypertensive treatment (from the LIFE echo-substudy).

Chinali M, Aurigemma GP, de Simone G, Mishra RK, Gerdts E, Wachtell K, Boman K, Dahlöf B, Devereux RB.

Am J Cardiol. 2009 Oct 15;104(8):1098-104.PMID: 19801032 [PubMed - indexed for MEDLINE]Related articles

[Hypertension and the heart]

Wachtell K, Andersen NH, Svendsen TL.

Ugeskr Laeger. 2009 Jun 15;171(25):2113-6. Danish. PMID: 19671394 [PubMed - indexed for MEDLINE]Related articles

Low-flow aortic stenosis in asymptomatic patients: valvular-arterial impedance and systolic function from the SEAS Substudy.

Cramariuc D, Cioffi G, Rieck AE, Devereux RB, Staal EM, Ray S, Wachtell K, Gerdts E.

JACC Cardiovasc Imaging. 2009 Apr;2(4):390-9.PMID: 19580719 [PubMed - indexed for MEDLINE]Related articles

Pulse pressure, left ventricular function and cardiovascular events during antihypertensive treatment (the LIFE study).

Gerdts E, Franklin S, Rieck A, Papademetriou V, Wachtell K, Nieminen M, Dahlof B, Devereux RB.

Blood Press. 2009 Jun 26:1-7. [Epub ahead of print]PMID: 19562573 [PubMed - as supplied by publisher]Related articles

Urine Albumin/Creatinine Ratio, High Sensitivity C-Reactive Protein and N-Terminal Pro Brain Natriuretic Peptide -Three new Cardiovascular Risk Markers -Do They Improve Risk Prediction and Influence Treatment?

Olsen MH, Sehestedt T, Lyngbæk S, Hansen TW, Rasmussen S, Wachtell K, Torp-Pedersen C, Hildebrandt PR, Ibsen H.

Curr Vasc Pharmacol. 2010 Jan 1. [Epub ahead of print]PMID: 19485906 [PubMed - as supplied by publisher]Related articles

[Transcatheter replacement of the aortic valve--a novel treatment modality for high-risk patients]

Olsen LK, Engstrøm T, Wachtell K, Kristensen T, Hassager C, Ihlemann N, Møller JE, Andersen LW, Olsen PS, Søndergaard L.

Ugeskr Laeger. 2009 Apr 6;171(15):1293-7. Review. Danish. PMID: 19416622 [PubMed - indexed for MEDLINE]Related articles

[Percutaneous aortic valve replacement - initial experience and results]

Olsen LK, Engstrøm T, Wachtell K, Kristensen T, Hassager C, Ihlemann N, Møller JE, Andersen LW, Olsen PS, Søndergaard L.

Ugeskr Laeger. 2009 Apr 6;171(15):1289-93. Danish. PMID: 19416621 [PubMed - indexed for MEDLINE]Related articles

Which markers of subclinical organ damage to measure in individuals with high normal blood pressure?

Sehestedt T, Jeppesen J, Hansen TW, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Olsen MH.

J Hypertens. 2009 Jun;27(6):1165-71.PMID: 19387364 [PubMed - indexed for MEDLINE]Related articles

Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE study.

Boman K, Gerdts E, Wachtell K, Dahlöf B, Nieminen MS, Olofsson M, Papademetriou V, Devereux RB.

Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):242-8.PMID: 19369828 [PubMed - indexed for MEDLINE]Related articles

Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study.

de Simone G, Okin PM, Gerdts E, Olsen MH, Wachtell K, Hille DA, Dahlöf B, Kjeldsen SE, Devereux RB.

Nutr Metab Cardiovasc Dis. 2009 Nov;19(9):634-40. Epub 2009 Apr 10.PMID: 19361968 [PubMed - in process]Related articles

Impact of diabetes on treatment-induced changes in left ventricular structure and function in hypertensive patients with left ventricular hypertrophy. The LIFE study.

Gerdts E, Okin PM, Omvik P, Wachtell K, Dahlöf B, Hildebrandt P, Nieminen MS, Devereux RB.

Nutr Metab Cardiovasc Dis. 2009 Jun;19(5):306-12. Epub 2009 Mar 19.PMID: 19303268 [PubMed - indexed for MEDLINE]Related articles

Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study.

Olsen MH, Wachtell K, Beevers G, Dahlöf B, de Simone G, Devereux RB, de Faire U, Fyhrquist F, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Lyle PA, Nieminen MS, Omvik P, Oparil S, Wedel H.

J Hypertens. 2009 Mar;27(3):567-74.PMID: 19262226 [PubMed - indexed for MEDLINE]Related articles

Prevention of congestive heart failure in high risk patients.

Wachtell K.

Eur Heart J. 2009 Mar;30(6):638-9. Epub 2009 Feb 24. No abstract available. PMID: 19240069 [PubMed - indexed for MEDLINE]Related articles

The left atrium, atrial fibrillation, and the risk of stroke in hypertensive patients with left ventricular hypertrophy.

Wachtell K, Devereux RB, Lyle PA, Okin PM, Gerdts E.

Ther Adv Cardiovasc Dis. 2008 Dec;2(6):507-13. Epub 2008 Aug 21. Review.PMID: 19124445 [PubMed - indexed for MEDLINE]Related articles

Does lowering cholesterol have an impact on the progression of aortic stenosis?

Greve AM, Wachtell K.

Ther Adv Cardiovasc Dis. 2008 Aug;2(4):277-86. Review.PMID: 19124427 [PubMed - indexed for MEDLINE]Related articles

Atrial fibrillation, maybe it is not so lone?

Wachtell K.

J Am Coll Cardiol. 2009 Jan 6;53(1):30-1. No abstract available. PMID: 19118721 [PubMed - indexed for MEDLINE]Related articles

Prognostic importance of hemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: the Losartan Intervention For End point reduction in hypertension (LIFE) study.

Olsen MH, Wachtell K, Beevers G, Dahlöf B, Devereux RB, de Faire U, Fyhrquist F, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Narayan P, Nieminen MS, Omvik P, Oparil S, Wedel H.

Am Heart J. 2009 Jan;157(1):177-84. Epub 2008 Oct 17.PMID: 19081416 [PubMed - indexed for MEDLINE]Related articles

Is it time to change the definition of normal urinary albumin excretion?

Wachtell K, Olsen MH.

Nat Clin Pract Nephrol. 2008 Dec;4(12):650-1. Epub 2008 Oct 14.PMID: 18852732 [PubMed]Related articles

New risk markers may change the HeartScore risk classification significantly in one-fifth of the population.

Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt PR.

J Hum Hypertens. 2009 Feb;23(2):105-12. Epub 2008 Sep 11.PMID: 18784734 [PubMed - indexed for MEDLINE]Related articles

Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.

Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Skjaerpe T, Wachtell K, Willenheimer R; SEAS Investigators.

N Engl J Med. 2008 Sep 25;359(13):1343-56. Epub 2008 Sep 2.PMID: 18765433 [PubMed - indexed for MEDLINE]Related articlesFree article

Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients with left ventricular hypertrophy and diabetes.

Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE.

J Nephrol. 2008 Jul-Aug;21(4):566-9.PMID: 18651547 [PubMed - indexed for MEDLINE]Related articles

Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study.

Chinali M, de Simone G, Wachtell K, Gerdts E, Gardin JM, Boman K, Nieminen MS, Papademetriou V, Dahlöf B, Devereux RB.

J Hypertens. 2008 Jul;26(7):1472-6.PMID: 18551025 [PubMed - indexed for MEDLINE]Related articles

Impact of the metabolic syndrome on the predictive values of new risk markers in the general population.

Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt PR.

J Hum Hypertens. 2008 Sep;22(9):634-40. Epub 2008 Jun 5.PMID: 18528412 [PubMed - indexed for MEDLINE]Related articles

Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study).

Gerdts E, Cramariuc D, de Simone G, Wachtell K, Dahlöf B, Devereux RB.

Eur J Echocardiogr. 2008 Nov;9(6):809-15. Epub 2008 May 13.PMID: 18490279 [PubMed - indexed for MEDLINE]Related articlesFree article

Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension study.

Li Z, Dahlöf B, Okin PM, Kjeldsen SE, Wachtell K, Ibsen H, Nieminen MS, Jern S, Devereux RB.

J Hypertens. 2008 Jun;26(6):1244-9.PMID: 18475164 [PubMed - indexed for MEDLINE]Related articles

Change in pulse pressure/stroke index in response to sustained blood pressure reduction and its impact on left ventricular mass and geometry changes: the life study.

Palmieri V, Bella JN, Gerdts E, Wachtell K, Papademetriou V, Nieminen MS, Dahlöf B, Devereux RB.

Am J Hypertens. 2008 Jun;21(6):701-7. Epub 2008 Apr 10.PMID: 18437127 [PubMed - indexed for MEDLINE]Related articles

Left atrial volume in patients with asymptomatic aortic valve stenosis (the Simvastatin and Ezetimibe in Aortic Stenosis study).

Dalsgaard M, Egstrup K, Wachtell K, Gerdts E, Cramariuc D, Kjaergaard J, Hassager C.

Am J Cardiol. 2008 Apr 1;101(7):1030-4. Epub 2008 Feb 6.PMID: 18359326 [PubMed - indexed for MEDLINE]Related articles

Clinical impact of 'in-treatment' wall motion abnormalities in hypertensive patients with left ventricular hypertrophy: the LIFE study.

Cicala S, de Simone G, Wachtell K, Gerdts E, Boman K, Nieminen MS, Dahlöf B, Devereux RB.

J Hypertens. 2008 Apr;26(4):806-12.PMID: 18327092 [PubMed - indexed for MEDLINE]Related articles

Factors influencing left ventricular structure and stress-corrected systolic function in men and women with asymptomatic aortic valve stenosis (a SEAS Substudy).

Cramariuc D, Rieck AE, Staal EM, Wachtell K, Eriksen E, Rossebø AB, Gerdts E.

Am J Cardiol. 2008 Feb 15;101(4):510-5. Epub 2007 Dec 20.PMID: 18312768 [PubMed - indexed for MEDLINE]Related articles

Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan Intervention for Endpoint Reduction in Hypertension Study.

Gerdts E, Okin PM, de Simone G, Cramariuc D, Wachtell K, Boman K, Devereux RB.

Hypertension. 2008 Apr;51(4):1109-14. Epub 2008 Feb 7.PMID: 18259011 [PubMed - indexed for MEDLINE]Related articlesFree article

Combination of the electrocardiographic strain pattern and albuminuria for the prediction of new-onset heart failure in hypertensive patients: the LIFE study.

Okin PM, Wachtell K, Devereux RB, Nieminen MS, Oikarinen L, Viitasalo M, Toivonen L, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Kjeldsen SE, Julius S, Dahlöf B; LIFE Study Investigators.

Am J Hypertens. 2008 Mar;21(3):273-9. Epub 2008 Jan 24.PMID: 18219298 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.

Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt PR.

J Hypertens. 2008 Jan;26(1):26-34.PMID: 18090537 [PubMed - indexed for MEDLINE]Related articles

Losartan versus atenolol on 24-hour ambulatory blood pressure. A LIFE substudy.

Bang LE, Wiinberg N, Wachtell K, Larsen J, Olsen MH, Tuxen C, Hildebrandt PR, Ibsen H.

Blood Press. 2007;16(6):392-7.PMID: 18058457 [PubMed - indexed for MEDLINE]Related articles

[Percutaneous assist device during acute heart failure]

Lindholm MG, Engstrøm T, Wachtell K, Boesgaard S, Sander K, Hassager C.

Ugeskr Laeger. 2007 Sep 24;169(39):3282-6. Review. Danish. PMID: 17953886 [PubMed - indexed for MEDLINE]Related articles

Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).

Idorn L, Høfsten DE, Wachtell K, Mølgaard H, Egstrup K; DANAMI-2 Investigators.

Am J Cardiol. 2007 Sep 15;100(6):937-43. Epub 2007 Jul 2.PMID: 17826373 [PubMed - indexed for MEDLINE]Related articles

Pre-discharge exercise test for evaluation of patients with complete or incomplete revascularization following primary percutaneous coronary intervention: a DANAMI-2 sub-study.

Valeur N, Clemmensen P, Grande P, Wachtell K, Saunamaki K.

Cardiology. 2008;109(3):163-71. Epub 2007 Aug 28.PMID: 17726317 [PubMed - indexed for MEDLINE]Related articles

The effect of angiotensin receptor blockers for preventing atrial fibrillation.

Wachtell K, Devereux RB, Lyle AP.

Curr Hypertens Rep. 2007 Aug;9(4):278-83. Review.PMID: 17686377 [PubMed - indexed for MEDLINE]Related articles

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.

Wachtell K, Okin PM, Olsen MH, Dahlöf B, Devereux RB, Ibsen H, Kjeldsen SE, Lindholm LH, Nieminen MS, Thygesen K.

Circulation. 2007 Aug 14;116(7):700-5. Epub 2007 Jul 30.PMID: 17664372 [PubMed - indexed for MEDLINE]Related articlesFree article

Electrocardiographic and echocardiographic detection of myocardial infarction in patients with left-ventricular hypertrophy. The LIFE Study.

Cicala S, Devereux RB, de Simone G, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Dahlöf B, Okin PM.

Am J Hypertens. 2007 Jul;20(7):771-6.PMID: 17586412 [PubMed - indexed for MEDLINE]Related articles

Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.

de Simone G, Olsen MH, Wachtell K, Hille DA, Dahlöf B, Ibsen H, Kjeldsen SE, Lyle PA, Devereux RB.

J Hum Hypertens. 2007 Aug;21(8):625-32. Epub 2007 May 3.PMID: 17476291 [PubMed - indexed for MEDLINE]Related articles

Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.

Palmieri V, Okin PM, de Simone G, Bella JN, Wachtell K, Gerdts E, Boman K, Nieminen MS, Dahlöf B, Devereux RB.

J Hypertens. 2007 May;25(5):1079-85.PMID: 17414673 [PubMed - indexed for MEDLINE]Related articles

Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study.

Rossebø AB, Pedersen TR, Allen C, Boman K, Chambers J, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi VA, Malbecq W, Nienaber C, Ray S, Skjaerpe T, Wachtell K, Willenheimer R.

Am J Cardiol. 2007 Apr 1;99(7):970-3. Epub 2007 Feb 15.PMID: 17398194 [PubMed - indexed for MEDLINE]Related articles

Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension: the RENAAL and LIFE studies.

Eijkelkamp WB, Zhang Z, Brenner BM, Cooper ME, Devereux RB, Dahlöf B, Ibsen H, Keane WF, Lindholm LH, Olsen MH, Parving HH, Remuzzi G, Shahinfar S, Snapinn SM, Wachtell K, de Zeeuw D.

J Hypertens. 2007 Apr;25(4):871-6.PMID: 17351381 [PubMed - indexed for MEDLINE]Related articles

N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population.

Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt PR.

Eur Heart J. 2007 Jun;28(11):1374-81. Epub 2007 Jan 22.PMID: 17242007 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevalence and prognostic implications of non-sustained ventricular tachycardia in ST-segment elevation myocardial infarction after revascularization with either fibrinolysis or primary angioplasty.

Høfsten DE, Wachtell K, Lund B, Mølgaard H, Egstrup K.

Eur Heart J. 2007 Feb;28(4):407-14. Epub 2007 Jan 16.PMID: 17227787 [PubMed - indexed for MEDLINE]Related articlesFree article

Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial.

Gerdts E, Wachtell K, Omvik P, Otterstad JE, Oikarinen L, Boman K, Dahlöf B, Devereux RB.

Hypertension. 2007 Feb;49(2):311-6. Epub 2006 Dec 18.PMID: 17178978 [PubMed - indexed for MEDLINE]Related articlesFree article

Does long-term losartan- vs atenolol-based antihypertensive treatment influence collagen markers differently in hypertensive patients? A LIFE substudy.

Christensen MK, Olsen MH, Wachtell K, Tuxen C, Fossum E, Bang LE, Wiinberg N, Devereux RB, Kjeldsen SE, Hildebrandt P, Rokkedal J, Ibsen H.

Blood Press. 2006;15(4):198-206.PMID: 17078155 [PubMed - indexed for MEDLINE]Related articles